IQVIA 

$178.25
131
-$3.21-1.77% Today

Statistics

Day High
183.34
Day Low
177.24
52W High
244.29
52W Low
154.1
Volume
183,871,427
Avg. Volume
-
Mkt Cap
30.25B
P/E Ratio
22.51
Dividend Yield
-
Dividend
-

Upcoming

Earnings

28JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
2.63
2.9
3.16
3.42
Expected EPS
3.038327
Actual EPS
N/A

Financials

8.34%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
32.62BRevenue
2.72BNet Income

Analyst Ratings

221.40Average Price Target
The highest estimate is 255.00.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
90%
Hold
10%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IQV. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Charles River Laboratories International
CRL
Mkt Cap9.03B
Charles River Laboratories provides a variety of preclinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology industries, competing directly with IQVIA's research services.
Icon Energy
ICON
Mkt Cap3.4M
ICON plc offers clinical research services, directly competing with IQVIA in the contract research organization (CRO) space, providing full-service clinical development services.
Medpace
MEDP
Mkt Cap13.35B
Medpace Holdings is a scientifically-driven, global full-service clinical contract research organization (CRO) that competes with IQVIA in providing phase I-IV clinical development services to the pharmaceutical and biotech industry.
Mettler-Toledo International
MTD
Mkt Cap22.86B
Mettler-Toledo International Inc. provides precision instruments and services for professional use, including drug development and research, overlapping with some of IQVIA's analytical and laboratory services.
Thermo Fisher Scientific
TMO
Mkt Cap174.42B
Thermo Fisher Scientific Inc. offers analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with IQVIA in the life sciences and laboratory services market.
Quest Diagnostics
DGX
Mkt Cap22.48B
Quest Diagnostics Incorporated provides diagnostic testing, information, and services, including clinical trials testing which competes with IQVIA's services in the healthcare and diagnostics market.

About

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Show more...
CEO
Mr. Ari Bousbib
Employees
89000
Country
United States
ISIN
US46266C1053

Listings

0 Comments

Share your thoughts

FAQ

What is IQVIA stock price today?
The current price of IQV is $178.25 USD — it has decreased by -1.77% in the past 24 hours. Watch IQVIA stock price performance more closely on the chart.
What is IQVIA stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange IQVIA stocks are traded under the ticker IQV.
Is IQVIA stock price growing?
IQV stock has fallen by -3.12% compared to the previous week, the month change is a +5.22% rise, over the last year IQVIA has showed a +13.42% increase.
What is IQVIA market cap?
Today IQVIA has the market capitalization of 30.25B
When is the next IQVIA earnings date?
IQVIA is going to release the next earnings report on July 28, 2026.
What were IQVIA earnings last quarter?
IQV earnings for the last quarter are 2.9 USD per share, whereas the estimation was 2.82 USD resulting in a +2.97% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is IQVIA revenue for the last year?
IQVIA revenue for the last year amounts to 32.62B USD.
What is IQVIA net income for the last year?
IQV net income for the last year is 2.72B USD.
How many employees does IQVIA have?
As of June 15, 2026, the company has 89,000 employees.
In which sector is IQVIA located?
IQVIA operates in the Health & Wellness sector.
When did IQVIA complete a stock split?
IQVIA has not had any recent stock splits.
Where is IQVIA headquartered?
IQVIA is headquartered in Durham, United States.